rVA576

Drug identity checked against registry records

Also recorded as nomacopan

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
rVA576 (Coversin) Long Term Safety and Efficacy Surveillance StudyNCT03829449AKARI TherapeuticsPhase 3Terminated2020-08-29Actual
Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576NCT03588026AKARI TherapeuticsPhase 3Completed2020-09-03Actual
rVA576 in Adult Mild to Moderate Bullous Pemphigoid SubjectsNCT04035733AKARI TherapeuticsPhase 2Completed2020-03-12Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.